BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36933117)

  • 21. Retrospective real-life study on preoperative imaging for minimally invasive parathyroidectomy in primary hyperparathyroidism.
    Bijnens J; Van den Bruel A; Vander Poorten V; Goethals I; Van Schandevyl S; Dick C; De Geeter F
    Sci Rep; 2022 Oct; 12(1):17427. PubMed ID: 36261462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatostatin receptor imaging with [
    Zhao L; Pang Y; Wang Y; Chen J; Zhuang Y; Zhang J; Zhao L; Sun L; Wu H; Chen X; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Mar; 49(4):1360-1373. PubMed ID: 34665275
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Parihar AS; Mittal BR; Kumar R; Shukla J; Bhattacharya A
    Thyroid; 2020 Apr; 30(4):557-567. PubMed ID: 31870227
    [No Abstract]   [Full Text] [Related]  

  • 24. PETC/CT with
    Bossert I; Chytiris S; Hodolic M; Croce L; Mansi L; Chiovato L; Mariani G; Trifirò G
    J Endocrinol Invest; 2019 Apr; 42(4):419-426. PubMed ID: 30094743
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accuracy of
    Hope TA; Graves CE; Calais J; Ehman EC; Johnson GB; Thompson D; Aslam M; Duh QY; Gosnell JE; Shen WT; Roman SA; Sosa JA; Kluijfhout WP; Seib CD; Villaneuva-Meyer JE; Pampaloni MH; Suh I
    J Nucl Med; 2021 Nov; 62(11):1511-1516. PubMed ID: 33674400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ¹⁸F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study.
    Lezaic L; Rep S; Sever MJ; Kocjan T; Hocevar M; Fettich J
    Eur J Nucl Med Mol Imaging; 2014 Nov; 41(11):2083-9. PubMed ID: 25063039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of
    Wang L; Tang G; Hu K; Liu X; Zhou W; Li H; Huang S; Han Y; Chen L; Zhong J; Wu H
    Radiology; 2022 Apr; 303(1):191-199. PubMed ID: 34981976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-individual comparison of
    Bénard F; Harsini S; Wilson D; Zukotynski K; Abikhzer G; Turcotte E; Cossette M; Metser U; Romsa J; Martin M; Mar C; Saad F; Soucy JP; Eigl BJ; Black P; Krauze A; Burrell S; Nichol A; Tardif JC
    Lancet Oncol; 2022 Dec; 23(12):1499-1507. PubMed ID: 36343655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical utility of [
    Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment and Comparison of
    Whitman J; Allen IE; Bergsland EK; Suh I; Hope TA
    J Nucl Med; 2021 Sep; 62(9):1285-1291. PubMed ID: 33452040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorine-18 fluorocholine PET-CT localizes hyperparathyroidism in patients with inconclusive conventional imaging: a multicenter study from the Netherlands.
    Kluijfhout WP; Vorselaars WM; van den Berk SA; Vriens MR; Borel Rinkes IH; Valk GD; van Dalen T; de Klerk JM; de Keizer B
    Nucl Med Commun; 2016 Dec; 37(12):1246-1252. PubMed ID: 27612033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [
    Pang Y; Shang Q; Meng T; Chen H
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1770-1771. PubMed ID: 34913095
    [No Abstract]   [Full Text] [Related]  

  • 33. Planar scintigraphy with 123I/99mTc-sestamibi, 99mTc-sestamibi SPECT/CT, 11C-methionine PET/CT, or selective venous sampling before reoperation of primary hyperparathyroidism?
    Schalin-Jäntti C; Ryhänen E; Heiskanen I; Seppänen M; Arola J; Schildt J; Väisänen M; Nelimarkka L; Lisinen I; Aalto V; Nuutila P; Välimäki MJ
    J Nucl Med; 2013 May; 54(5):739-47. PubMed ID: 23554505
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superior sensitivity of
    Graves CE; Hope TA; Kim J; Pampaloni MH; Kluijfhout W; Seib CD; Gosnell JE; Shen WT; Roman SA; Sosa JA; Duh QY; Suh I
    Surgery; 2022 Jan; 171(1):47-54. PubMed ID: 34301418
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary Hyperparathyroidism: Defining the Appropriate Preoperative Imaging Algorithm.
    Hindié E; Schwartz P; Avram AM; Imperiale A; Sebag F; Taïeb D
    J Nucl Med; 2021 Jul; 62(Suppl 2):3S-12S. PubMed ID: 34230072
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of [
    Li C; Tian Y; Chen J; Jiang Y; Xue Z; Xing D; Wen B; He Y
    Eur Radiol; 2023 Apr; 33(4):2779-2791. PubMed ID: 36394603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic and functional imaging employment in the differentiation of brown tumors from bone metastases in a case of primary papillary thyroid cancer and parathyroid adenoma: case report.
    Al-Rasheed U; Barakat F; Al-Ibraheem A
    J Egypt Natl Canc Inst; 2021 Oct; 33(1):30. PubMed ID: 34657985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. (18)F-FDG positron emission tomography/computed tomography and (99m)Tc-MDP skeletal scintigraphy in a case of Erdheim-Chester disease.
    Asabella AN; Cimmino A; Altini C; Notaristefano A; Rubini G
    Hell J Nucl Med; 2011; 14(3):311-2. PubMed ID: 22087457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Added value of 18F-fluorocholine positron emission tomography-computed tomography in presurgical localization of hyperfunctioning parathyroid glands after dual tracer subtraction scintigraphy failure: A retrospective study of 47 patients.
    Morland D; Lalire P; Deguelte S; Zalzali M; Richard C; Dejust S; Boulagnon C; Ly S; Papathanassiou D; Delemer B
    Medicine (Baltimore); 2020 Jan; 99(2):e18681. PubMed ID: 31914064
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [
    Lin R; Lin Z; Chen Z; Zheng S; Zhang J; Zang J; Miao W
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2960-2971. PubMed ID: 35462566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.